ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

EVLO Evelo Biosciences Inc

0.3165
0.00 (0.00%)
Last Updated: 00:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type
Evelo Biosciences Inc NASDAQ:EVLO NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.3165 0.3051 0.3114 0 00:00:00

Evolve One 8 For 1 Forward Stock Split Revised to Be Quoted, on a Post-Split Basis as of Tuesday, December 7th, 2004

30/11/2004 8:42pm

PR Newswire (US)


Evelo Biosciences (NASDAQ:EVLO)
Historical Stock Chart


From Jan 2020 to Jan 2025

Click Here for more Evelo Biosciences Charts.
Evolve One 8 For 1 Forward Stock Split Revised to Be Quoted, on a Post-Split Basis as of Tuesday, December 7th, 2004 The Record Date for the Split Is to Remain Friday, December 3rd, 2004 BOCA RATON, Fla., Nov. 30 /PRNewswire-FirstCall/ -- Evolve One, Inc. (OTC:EVLO) (BULLETIN BOARD: EVLO) announced today that the Board of Directors has approved an 8 for 1 forward stock split of the Company's common stock increasing the outstanding shares from 3,266,304 to approximately 26,130,432 shares, subject to rounding. The record day for the split is Friday, December 3rd, 2004 with the distribution date set at the close of business, Monday, December 6th, 2004. The Company's common stock will be quoted, on a post-split basis, as of Tuesday, December 7th, 2004. The Company has previously mailed an information statement to its stockholders notifying the stockholders as to this action, which does not require shareholders to take any further action. Existing certificates representing pre-split shares should not be destroyed or returned to the company and will continue to represent the same number of shares indicated. New certificates representing the additional shares of common stock will be mailed on the distribution date by the Company's transfer agent without any action by the stockholders. The split will involve no change in Evolve One's CUSIP number or its trading symbol. About Evolve One, Inc. Evolve One, Inc. ("EVLO") is a holding company that develops and operates Internet and direct retail marketing companies. EVLO includes wholly-owned subsidiaries, StogiesOnline.com, Inc., A1Discount Perfume, Inc., AuctionStore.com and International Internet Venture I, LLC. This press release contains forward looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), and as such, may involve risks and uncertainties. Forward-looking statements, which are based on certain assumptions and describe future plans, strategies, and expectations, are generally identifiable by the use of words such as "believe", "expect", "intend" "anticipate", "estimate", "project", or similar expressions. These forward-looking statements relate to, among other things, expectations of the business environment in which the Company operates, projections of future performance, potential future performance, perceived opportunities in the market, and statements regarding the Company's mission and vision. The Company's actual results, performance, and achievements may differ materially from the results, performance, and achievements expressed or implied in such forward-looking statements due to a wide range of factors which are set forth in our annual report on Form 10-KSB on file with the SEC. For further information, contact Gary J. Schultheis (561) 988-0819 DATASOURCE: Evolve One, Inc. CONTACT: Gary J. Schultheis of Evolve One, Inc., +1-561-988-0819

Copyright

1 Year Evelo Biosciences Chart

1 Year Evelo Biosciences Chart

1 Month Evelo Biosciences Chart

1 Month Evelo Biosciences Chart